References
- 1. Weber DJ, Rutala WA, Fischer WA, Kanamori H, Sickbert-Bennett EE. Emerging infectious diseases: focus on infection control issues for novel coronaviruses (severe acute respiratory syndrome-CoV and Middle East respiratory syndrome-CoV), hemorrhagic fever viruses (Lassa and Ebola), and highly pathogenic avian influenza viruses, A (H5N1) and A (H7N9). Am J Infect Control. 2016;44(5Suppl):e91-e100.10.1016/j.ajic.2015.11.018713265027131142
- 2. Al-Osail AM, Al-Wazzah MJ. The history and epidemiology of Middle East respiratory syndrome corona virus. Multidiscip Respir Med. 2017;12:20.10.1186/s40248-017-0101-8554584228794876
- 3. Li F. Structure, Function, and Evolution of Coronavirus Spike Proteins. Annu Rev Virol. 2016;3:237-261.10.1146/annurev-virology-110615-042301545796227578435
- 4. Li B, Li X, Wang Y, et al. Diagnostic value and key features of computed tomography in Coronavirus Disease 2019. Emerg Microbes Infect. 2020;9:787-793.10.1080/22221751.2020.1750307719189532241244
- 5. Zhu N, Zhang D, Wang W, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020;382:727-733.10.1056/NEJMoa2001017709280331978945
- 6. Eurosurveillance Editorial T. Note from the editors: World Health Organization declares novel coronavirus (2019-nCoV) sixth public health emergency of international concern. Euro Surveill. 2020;25: 200131e.10.2807/1560-7917.ES.2020.25.5.200131e701466932019636
- 7. Shi H, Han X, Zheng C. Evolution of CT Manifestations in a Patient Recovered from 2019 Novel Coronavirus (2019-nCoV) Pneumonia in Wuhan, China. Radiology. 2020;295:20.10.1148/radiol.2020200269723335932032497
- 8. Plaçais L, Richier Q. COVID-19: caractéristiques cliniques, biologiques et radiologiques chez l’adulte, la femme enceinte et l’enfant. Une mise au point au cœur de la pandémie [COVID-19: Clinical, biological and radiological characteristics in adults, infants and pregnant women. An up-to-date review at the heart of the pandemic]. Rev Med Interne. 2020;41:308-318.10.1016/j.revmed.2020.04.004716490732334862
- 9. Lauer SA, Grantz KH, Bi Q, Jones FK, Zheng Q, Meredith HR. The incubation period of coronavirus disease 2019 (COVID-19) from publicly reported confirmed cases: estimation and application. Ann Intern Med. 2020:M20-M0504.10.1101/2020.02.02.20020016
- 10. Pan F, Ye T, Sun P, et al. Time course of lung changes on chest CT during recovery from 2019 novel coronavirus (COVID-19) pneumonia. Radiology. 2020:295:715-721.10.1148/radiol.2020200370723336732053470
- 11. Bernheim A, Mei X, Huang M, et al. Chest CT findings in coronavirus disease-19 (COVID-19): Relationship to Duration of infection. Radiology. 2020:200463.10.1148/radiol.2020200463
- 12. Xia T, Li J, Gao J, Xu X. Small Solitary Ground-Glass Nodule on CT as an Initial Manifestation of Coronavirus Disease 2019 (COVID-19) Pneumonia. Korean J Radiol. 2020;21:545-549.10.3348/kjr.2020.0240
- 13. Lu T, Pu H. Computed Tomography Manifestations of 5 Cases of the Novel Coronavirus Disease 2019 (COVID-19) Pneumonia From Patients Outside Wuhan. J Thorac Imaging. 2020;35:W90-W93.10.1097/RTI.0000000000000508
- 14. Bhat R, Hamid A, Kunin JR, et al. Chest Imaging in Patients Hospitalized With COVID-19 Infection - A Case Series. Current Problems in Diagnostic Radiology. 2020;S0363-0188(20)30055-4.10.1067/j.cpradiol.2020.04.001
- 15. Schmitt W, Marchiori E. Covid-19: round and oval areas of ground-glass opacity. Pulmonology. 2020; S2531-0437(20)30084-2.10.1016/j.pulmoe.2020.04.001
- 16. Xiong Y, Sun D, Liu Y, et al. Clinical and High-Resolution CT Features of the COVID-19 Infection: Comparison of the Initial and Follow-up Changes. Invest Radiol. 2020;55:332-339.10.1097/RLI.0000000000000674
- 17. Du RH, Liang LR, Yang CQ, Wang W, Cao TZ, Li M, Guo GY, Du J, Zheng CL, Zhu Q, Hu M, Li XY, Peng P, Shi HZ. Predictors of mortality for patients with COVID-19 pneumonia caused by SARS-CoV-2: a prospective cohort study. Eur Respir J. 2020;55:2000524.10.1183/13993003.00524-2020
- 18. WHO Coronavirus Disease (COVID-19) Dashboard. https://covid19.who.int/?gclid=EAIaIQobChMIn7mIoOPU6QIVBouyCh2xQAMIEAAYASAAEgK03PD_BwE.
- 19. Abd El-Aziz TM, Stockand JD. Recent progress and challenges in drug development against COVID-19 coronavirus (SARS-CoV-2) – an update on the status. Infect Genet Evol. 2020;83:104327.10.1016/j.meegid.2020.104327
- 20. Rahman MT, Idid SZ. Can Zn Be a Critical Element in COVID-19 Treatment? Biol Trace Elem Res. 2020;1-9.10.1007/s12011-020-02194-9
- 21. Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497-506.10.1016/S0140-6736(20)30183-5
- 22. Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395:507-513.10.1016/S0140-6736(20)30211-7
- 23. Li Y, Xia L. Coronavirus Disease 2019 (COVID-19): Role of Chest CT in Diagnosis and Management. AJR Am J Roentgenol. 2020;4:1-7.10.2214/AJR.20.2295432130038
- 24. Yang Q, Liu Q, Xu H, Lu H, Liu S, Li H. Imaging of coronavirus disease 2019: A Chinese expert consensus statement. Eur J Radiol. 2020;127:109008.10.1016/j.ejrad.2020.109008716510532335426
- 25. Kanne JP. Chest CT findings in 2019 novel coronavirus (2019-nCoV) infections from Wuhan, China: key points for the radiologist. Radiology. 2020;295:16-17.10.1148/radiol.2020200241723336232017662
- 26. Guzik TJ, Mohiddin SA, Dimarco A, et al. COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options. Cardiovasc Res. 2020;116:1666-1687.10.1093/cvr/cvaa106719762732352535
- 27. Geng YJ, Wei ZY, Qian HY, Huang J, Lodato R, Castriotta RJ. Pathophysiological characteristics and therapeutic approaches for pulmonary injury and cardiovascular complications of coronavirus disease 2019. Cardiovasc Pathol. 2020;47:107228.10.1016/j.carpath.2020.107228716277832375085
- 28. Tan ZC, Fu LH, Wang DD, Hong K. [Cardiac manifestations of patients with COVID-19 pneumonia and related treatment recommendations]. Zhonghua Xin Xue Guan Bing Za Zhi. 2020;48:E005.
- 29. Skulstad H, Cosyns B, Popescu BA, et al. COVID-19 pandemic and cardiac imaging: EACVI recommendations on precautions, indications, prioritization, and protection for patients and healthcare personnel. Eur Heart J Cardiovasc Imaging. 2020;21:592-598.10.1093/ehjci/jeaa072718434132242891
- 30. Cosyns B, Lochy S, Luchian ML, et al. The role of cardiovascular imaging for myocardial injury in hospitalized COVID-19 patients. Eur Heart J Cardiovasc Imaging. 2020;21:709-714.10.1093/ehjci/jeaa136723920732391912
- 31. Yang W, Cao Q, Qin L, et al. Clinical characteristics and imaging manifestations of the 2019 novel coronavirus disease (COVID-19):A multi-center study in Wenzhou city, Zhejiang, China. J Infect. 2020;80:388-393.10.1016/j.jinf.2020.02.016710253932112884
- 32. Inciardi RM, Lupi L, Zaccone G, et al. Cardiac Involvement in a Patient With Coronavirus Disease 2019 (COVID-19). JAMA Cardiol. 2020;5:819-824.10.1001/jamacardio.2020.1096736433332219357
- 33. Shi S, Qin M, Shen B, et al. Association of Cardiac Injury With Mortality in Hospitalized Patients With COVID-19 in Wuhan, China. JAMA Cardiol. 2020;5:802-810.10.1001/jamacardio.2020.0950709784132211816